BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22320984)

  • 1. The impact of mammographic breast cancer screening in Singapore: a comparison between screen-detected and symptomatic women.
    Wang WV; Tan SM; Chow WL
    Asian Pac J Cancer Prev; 2011; 12(10):2735-40. PubMed ID: 22320984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of breast cancer through population-based mammographic screening in Asian women: a comparison study between screen-detected and symptomatic breast cancers.
    Chuwa EW; Yeo AW; Koong HN; Wong CY; Yong WS; Tan PH; Ho JT; Wong JS; Ho GH
    Breast J; 2009; 15(2):133-9. PubMed ID: 19292798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
    Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
    Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
    Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
    BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study.
    Seneviratne S; Campbell I; Scott N; Shirley R; Lawrenson R
    BMC Public Health; 2015 Jan; 15():46. PubMed ID: 25637343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.
    Chuang SL; Chen SL; Yu CP; Chang KJ; Yen AM; Chiu SY; Fann JC; Tabár L; Stephen DW; Smith RA; Chen HH
    APMIS; 2014 Aug; 122(8):699-707. PubMed ID: 25046200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey on mammographic screening among women aged 40 to 65 years old at polyclinics.
    Leong HS; Heng R; Emmanuel SC
    Singapore Med J; 2007 Jan; 48(1):34-40. PubMed ID: 17245514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent prognostic value of screen detection in invasive breast cancer.
    Mook S; Van 't Veer LJ; Rutgers EJ; Ravdin PM; van de Velde AO; van Leeuwen FE; Visser O; Schmidt MK
    J Natl Cancer Inst; 2011 Apr; 103(7):585-97. PubMed ID: 21350218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does screen-detected breast cancer have better survival than symptomatic breast cancer?
    Yassin MM; Peel AL; Thompson WD; Patton J; Ashton V; Leaper DJ
    Asian J Surg; 2003 Apr; 26(2):101-7. PubMed ID: 12732494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
    Shen Y; Yang Y; Inoue LY; Munsell MF; Miller AB; Berry DA
    J Natl Cancer Inst; 2005 Aug; 97(16):1195-203. PubMed ID: 16106024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer in Singapore: some perspectives.
    Jara-Lazaro AR; Thilagaratnam S; Tan PH
    Breast Cancer; 2010; 17(1):23-8. PubMed ID: 19701678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.
    Meshkat B; Prichard RS; Al-Hilli Z; Bass GA; Quinn C; O'Doherty A; Rothwell J; Geraghty J; Evoy D; McDermott EW
    Breast; 2015 Jun; 24(3):278-82. PubMed ID: 25771080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer risk stratification for mammographic screening: A nation-wide screening cohort of 24,431 women in Singapore.
    Ho PJ; Wong FY; Chay WY; Lim EH; Lim ZL; Chia KS; Hartman M; Li J
    Cancer Med; 2021 Nov; 10(22):8182-8191. PubMed ID: 34708579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favourable prognostic factors of subsequent screen-detected breast cancers among women aged 50-69.
    Chiarelli AM; Edwards SA; Sheppard AJ; Mirea L; Chong N; Paszat L; Shumak RS; Oʼmalley FP;
    Eur J Cancer Prev; 2012 Nov; 21(6):499-506. PubMed ID: 22273849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of clinicopathological characteristics and long-term survival outcomes between symptomatic and screen-detected breast cancer in Japanese women.
    Inari H; Shimizu S; Suganuma N; Yoshida T; Nakayama H; Yamanaka T; Yamanaka A; Rino Y; Masuda M
    Breast Cancer; 2017 Jan; 24(1):98-103. PubMed ID: 26868519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length bias.
    Lawrence G; Wallis M; Allgood P; Nagtegaal ID; Warwick J; Cafferty FH; Houssami N; Kearins O; Tappenden N; O'Sullivan E; Duffy SW
    Breast Cancer Res Treat; 2009 Jul; 116(1):179-85. PubMed ID: 18622697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digital compared to screen-film mammography: breast cancer prognostic features in an organized screening program.
    Prummel MV; Done SJ; Muradali D; Majpruz V; Brown P; Jiang H; Shumak RS; Yaffe MJ; Holloway CM; Chiarelli AM
    Breast Cancer Res Treat; 2014 Sep; 147(2):389-99. PubMed ID: 25108740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.